On June 11, 2020, Regeneron Pharmaceuticals initiated the first of its randomized, placebo-controlled clinical trials of REGN-COV2, its experimental dual antibody cocktail for the prevention and treatment of COVID-19. Th e trials were conducted at multiple sites and consisted of four study populations—hospitalized COVID-19 patients, non- hospitalized symptomatic COVID-19 patients, …
Read More »Trumping COVID-19
Early on October 2, 2020, U.S. President Donald Trump, 74, revealed that he had tested positive for the novel corona virus. A day earlier, he had tested positive on a rapid test used for screening White House staff , which was later confirmed by a more accurate lab test. He …
Read More »
Medicosnext